RxSaludable NAD+ prices
5 figures read September 2026.
RxSaludable publishes 2 standing monthly rates for NAD+, from $169–$189, each charged on a calendar month — which makes it one of the minority of sellers in this index whose headline number is the number charged again next month.
What RxSaludable publishes
RxSaludable publishes a standing rate charged by the calendar month. Of the 46 sellers in this index that fall in the same bucket, that puts it with the 43% of the roster that publishes this shape of number rather than another one. That is the shape a buyer can act on directly, and 46 of 106 sellers here manage it.
The figure above is a standing rate, “/mo after”. This site never prints a price without that qualifier, on any surface, because the same number means a different thing depending on it — and in this corpus the same seller often prints several.
Every figure RxSaludable publishes — 5 figures, read September 2026
| Figure | What it is | Cycle, in their words | Route | Dose | Read |
|---|---|---|---|---|---|
| $109 | first period | “first month” | SubQ | 1000 mg per vial (200 mg/mL), 5 mL vial | September 2026 |
| $169 | standing rate | “/mo after” | SubQ | 1000 mg per vial (200 mg/mL), 5 mL vial | September 2026 |
| $129 | first period | “first month” | SubQ | 1000 mg per vial (200 mg/mL), 5 mL vial | September 2026 |
| $189 | standing rate | “/mo after” | SubQ | 1000 mg per vial (200 mg/mL), 5 mL vial | September 2026 |
| $15 | unresolved | no cycle stated | SubQ | 1000 mg per vial (200 mg/mL), 5 mL vial | September 2026 |
In RxSaludable’s own words
- $109 first period
The page says: “3-Month Plan $109first month”
The 3-Month Plan's first-month figure; the same block prints '$169/mo after'. Footnote: '*Price shown applies to 3-Month plan paid upfront. Actual price will depend on plan prescribed.'
Read from https://rxsaludable.com/nad-plus on September 2026.
- $169 standing rate
The page says: “$169/mo after”
The ongoing rate printed under the 3-Month Plan.
Read from https://rxsaludable.com/nad-plus on September 2026.
- $129 first period
The page says: “Monthly Plan $129first month”
The Monthly Plan's first-month figure; the same block prints '$189/mo after'.
Read from https://rxsaludable.com/nad-plus on September 2026.
- $189 standing rate
The page says: “$189/mo after”
The ongoing rate printed under the Monthly Plan.
Read from https://rxsaludable.com/nad-plus on September 2026.
- $15 unresolved
The page says: “Only $15/shot*, homekit included.”
Not resolved. A per-SHOT figure the seller derives from a plan price - not a purchasable plan. It carries an asterisk whose footnote is not printed anywhere in visible text (the page's only footnotes concern the 3-Month plan price).
A per-shot figure carrying an asterisk; the only footnotes printed in visible text are about the 3-Month plan price, so the page publishes no matching footnote for this one. The vial is described as 'Best for those aiming for higher frequency (up to 5x/week)'.
Read from https://rxsaludable.com/nad-plus on September 2026.
Price disclosure score: 100 of 100
This scores what RxSaludable publishes about its price, and nothing else. It is not a rating of the product, the clinic, the prescriber or the value — this site has read a price page, not used a product. Across all 106 sellers in the index the scores run from 6 to 100, with a median of 72. RxSaludable sits 7 of 106.
| What is scored | What RxSaludable publishes | Points |
|---|---|---|
| An exact figure | The headline figure is an exact charge for a defined purchase, not a floor and not a first-period rate. | 30of 30 |
| A stated cadence | The seller states the interval it bills on, so a reader knows when the next charge lands. | 20of 20 |
| Visible on the page | Every headline figure (2 figures) is printed where a reader can see it. | 20of 20 |
| A stated route | The seller states how the product is administered, in its own sentence. | 15of 15 |
| A stated dose | Every one of this seller's 5 figures states the dose it buys. | 15of 15 |
| Price disclosure score | This scores what the seller publishes about its price — not the product, the clinic, the prescriber or the value. | 100of 100 |
What RxSaludable does not publish
Each of these is a count over what was actually read, not an impression. 5 figures were read from this seller, and every sentence below is measured against that number.
- 1 of 5 figures could not be resolved into a price at all. Each carries the reason on this page, and none of them is estimated, averaged or guessed at.
Figures visible to a reader on the seller’s page
5 of 5
Figures stating a dose
5 of 5
Figures that resolve to a usable price
4 of 5
Source: Counted over the 5 figures read from RxSaludable’s own pages, September 2026. Each track is that figure count.
Where RxSaludable sits
60 other sellers in this index also state a SubQ route. Ranked with them on price disclosure, RxSaludable is 7 of 61. That is a statement about how completely each one publishes a price, and about nothing else — the figures behind those rows are different kinds of number and several of them state no dose, so they are not a like-for- like price comparison and this site does not present them as one.
Boards RxSaludable appears on
The reading record
This site has read RxSaludable once, in September 2026. A movement can only be shown between two readings taken here, so there is nothing to show yet — and a single reading is a fact about this site's record, never a statement that the seller held its price.
Figures are read from RxSaludable’s own public pages and recorded with the date. What counts as a price, and why a “from” figure is recorded as a floor rather than a rate, is set out on the editorial policy page. Prices in this category move quietly, so the figure above is what the page said on September 2026 and not a promise about today.